Journals / Türk Biyokimya Dergisi / 2016 / Cilt: 41 - Sayı: 6

Rekürren adenotonsillitte antimikrobiyel peptidlerin ekspresyonu

Expression of antimicrobial peptides in recurrent adenotonsillitis

Pages
437–442
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Moreover hBD-2 expression was different in adenoid tissue than control (p < 0.05).Conclusion:Antimicrobialpeptideshavekeyroleinadenotonsillar infections and this defense mechanism increases susceptibility to recurrent infections in upper respiratory tract.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Recurrent acute tonsillitis is one of the most frequent otorhinolaryngology clinic referrals, yet its pathogenesis remains poorly understood.
📊
Key Findings & Data:Materials and methods: The study is done with 100 children who had a history of recurrent adenotonsillitis as subject group and 100 children with adenotonsillar hypertrophy as control group.
💡
Conclusion & Impact:Moreover hBD-2 expression was different in adenoid tissue than control (p < 0.05).Conclusion:Antimicrobialpeptideshavekeyroleinadenotonsillar infections and this defense mechanism increases susceptibility to recurrent infections in upper respiratory tract.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background: Recurrent acute tonsillitis is one of the most frequent otorhinolaryngology clinic referrals, yet its pathogenesis remains poorly understood. Antimicrobial cationic peptides are components of the innate system. They are generally small, highly positively charged peptides with broad spectrum antimicrobial activity which function as the body's "natural antibiotics". Our aim is to investigate the role of antimicrobial cationic peptides in the susceptibility of patients to recurrent acute tonsillitis. Materials and methods: The study is done with 100 children who had a history of recurrent adenotonsillitis as subject group and 100 children with adenotonsillar hypertrophy as control group. Tonsillar and adenoid tissues are dissected into parts as deep and surface epithelium and investigated semiquantitatively with immunohistochemistry. Human beta defensin (hBD) 1-3 and cathelecidin (LL-37) levels are compared with microscopically. Results: Immunohistochemistry revealed a strong expression of hBD-1, hBD-2 and hBD-3 in tonsillar tissue. Quantification of hBD-1, hBD-2 and hBD-3 expressions are shown more in tonsillar tissue than in adenoids. LL-37 is one of the antimicrobial peptides found in human tonsil-lar tissue and adenoids, that participates in the innate immunesystemofthesetissues.Statistically,hBD-1,hBD-3 and LL-37 expressions were different in recurrent tonsillitis tissue than control (p < 0.05). Moreover hBD-2 expression was different in adenoid tissue than control (p < 0.05).Conclusion:Antimicrobialpeptideshavekeyroleinadenotonsillar infections and this defense mechanism increases susceptibility to recurrent infections in upper respiratory tract.

Özet

Giriş: Rekürren akut tonsillitis, kulak burun boğaz kliniğinde sıklıkla görülmektedir fakat patogenezi çok az bilinmektedir. Antimikrobiyal katyonik peptidler doğuştan olan bağışıklık sisteminin parçasıdır. Bu peptidler genel olarak küçük, pozitif yüklü peptidlerdir. Ayrıca vücudumuzun doğal antibiyotiği olarak görev yapan geniş spektrumlu antimikrobiyal aktivite göstermektedirler.Amacımız hastaların tekrarlanan akut tonsillitise duyarlılıklarında antimikrobiyal katyonik peptidlerin rolünü incelemektir.Metod: çalışma grubunu rekürren adenotosillit öyküsü olan 100 hasta, kontrol grubunu ise adenotonsiller hipertrofisi olan 100 çocuk oluşturmaktadır. tonsil ve adenoid doku yüzeyel ve derin dokulara ayrılacak şekilde diseke edilmiştir ve semikantitatif olarak immunuhistokimyasal olarak incelenmiştir. human beta defensin (hBD) 1-3 ve katlesidin (LL-37) seviyeleri mikroskopik olarak karşılaştırılmıştır.Bulgular: İmmunohistokimyasal değerlendirmede tonsil dokusunda yüksek HbD1, HbD2 ve Hbd3 ekspresyonu mevcuttur. tonsil dokusunda adenoid dokusuna göre daha fazla HbD1, HbD2 ve Hbd3 seviyesi mevcuttur. LL-37 insan tonsil ve adenoid dokusunda yeralan ve doğumsal immun sistemin bir parçası antimikrobiyal peptiddir. hBD1, hBD2 ve LL-37 seviyeleri rekürren tonsillit ve kontrol grubunda istatistiki olarak farklıdır (p < 0.05). Ayrıca hBd2 ekspresyonu adenoid dokuda kontrol grubuna göre farklıdır (p < 0.05).Sonuç: Antimikrobiyel peptidler adenotonsiller enfeksiyonlarda anahtar role sahiptir ve bu defans mekanizması üst solunum yolunda rekürren enfeksiyonlarda hassasiyeti artırır

🔖

Cite This Article

DEMİR, M. G., KILIÇ, M., AYDIN, S., ATALAY, B. E., ÖZDEMİR, N. B., OĞUZTÜZÜN, S. (2022). Rekürren adenotonsillitte antimikrobiyel peptidlerin ekspresyonu. Türk Biyokimya Dergisi, Cilt: 41 - Sayı: 6, 437–442. https://ajindex.com/articles/621047

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Brandzaeg P. Immune function of nasopharyngeal tissue. Adv Otorhinolaryngol 2011;72:20-4. Brandtzaeg P. Immunology of tonsils and adenoids: everything the ENT surgeon needs to know. Int J Pediatr Otorhinolaryngol;67:S69-76. Yeaman MR, Yount NY. Mechanisms of antimicrobial peptide action and resistance. Pharmacological reviews;55:27-55. Bals R. Epithelial antimicrobial peptides in host defense against infection. Respir Res 2000;1:141-50.
  2. Bals R, Wilson JM. Cathelicidins-a family of multifunctional antimicrobial peptides. Cell Mol Life Sci 2003;60:711-20. Zaslo VM. Antimicrobial peptides of multicellular organisms. Nature 2002;415:389-95.
  3. McCray P Jr, Bentley L. Human airway epithelia express a beta defensin. Am J Respir Cell Mol Biol 1997;16:343-9.
  4. Valore EV, Park CH, Quayle AJ, Wiles KR, McCray PB Jr, Ganz T. Human beta defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest 1998;101:1633-42.
  5. Sİrensen OE, Thapa DR, Rosenthal A, Liu L, Roberts AA, Ganz T. Differential regulation of defensin expression in human skin by microbial stimuli. J Immunol 2005;174:4870-9.
  6. Schröder J-M, Harder J. Human beta-defensin-2. Int J Biochem Cell Biol 1999;31:645-51.
  7. Harder J, Bartels J, Christophers E, Schröder JM. Isolation and characterization of human beta defensin-3, a novel human inducible peptide antibiotic. J Biol Chem Vol;276:5707-13.
  8. Ishimoto H, Mukae H, Date Y, Shimbara T, Mondal MS, Ashitani J, et al. Identifcation of hBD-3 in respiratory tract and serum: the increase in pneumonia. Eur Respir J 2006;27:253-60.
  9. VanderSpek JC, Offner GD, Troxler RF, Oppenheim FG. Molecular cloning of human submandibular histatins. Arch Oral Biol;35:137-43.
  10. Steinstraesser L, Oezdogan Y, Wang SC, Steinau HU. Host defense peptides in burns. Burns 2004;30:619-27.
  11. Gennaro R, Zanetti M. Structural features and biological activi- ties of the cathelicidin-derived antimicrobial peptides. Biopoly- mers 2000;55:31-49.
  12. Hancock RE, Diamond G. The role of cationic antimicrobial pep- tides in innate host defences. Trends Microbiol 2000;8:402-10. Brook I. The role of beta-lactamase producing bacteria and bacterial interference in streptococcal tonsillitis. Int J Antimicrob Agents 2001;17:439-42.
  13. Baugh RF, Archer SM, Mitchell RB. Clinical practice guidelines: ton- sillectomy in children. Otolaryngol Head Neck Surg 2010;144:1-30.
  14. Stenfors LE, Bye HM, Raisanen S. Noticeable differences in bac- terial defence on tonsillar surfaces between bacteria-induced and virus-induced acute t